Organon & Co.
Here’s whether Organon & Co. (OGN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 3-month momentum positive (+11.4%); rising volume confirms the move (1.81x 30d avg). Concerns: 50-day MA is falling (-2.43% over 10 days); RSI 83 — overbought, elevated pullback risk. Currently 26.3% off its 52-week high. Score: +3/7.
OGN is in a confirmed uptrend, trading above both its 50-day ($7.08) and 200-day ($8.37) moving averages. With an RSI of 83.1, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -9.8% compares to +35.1% for SPY (trailed the market by 44.9%). The current 26.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.